Abstract
Radiotherapy is an important treatment option for many human cancers. Current research is investigating the use of molecular targeted drugs in order to improve responses to radiotherapy in various cancers. The cellular response to irradiation is driven by both direct DNA damage in the targeted cell and intercellular signalling leading to a broad range of bystander effects.
This study aims to elucidate radiation-induced DNA damage response signalling in bystander cells and to identify potential molecular targets to modulate the radiation induced bystander response in a therapeutic setting.
Stalled replication forks in T98G bystander cells were visualised via bromodeoxyuridine (BrdU) nuclear foci detection at sites of single stranded DNA. γH2AX co-localised with these BrdU foci. BRCA1 and FANCD2 foci formed in T98G bystander cells. Using ATR mutant F02-98 hTERT and ATM deficient GM05849 fibroblasts it could be shown that ATR but not ATM was required for the recruitment of FANCD2 to sites of replication associated DNA damage in bystander cells whereas BRCA1 bystander foci were ATM-dependent. Phospho-Chk1 foci formation was observed in T98G bystander cells. Clonogenic survival assays showed moderate radiosensitisation of directly irradiated cells by the Chk1 inhibitor UCN-01 but increased radioresistance of bystander cells.
This study identifies BRCA1, FANCD2 and Chk1 as potential targets for the modulation of radiation response in bystander cells. It adds to our understanding of the key molecular events propagating out-of-field effects of radiation and provides a rationale for the development of novel molecular targeted drugs for radiotherapy optimisation.
Introduction
Radiotherapy is a main treatment option for cancer patients, often combined with surgery and chemotherapy. Direct effects of radiation and their modulation for the benefit of treatment outcome (e.g. fractionation) have been extensively studied and this has led to much improved survival rates. In the last decade, radiationinduced non-targeted bystander responses have increasingly been a focus of research, and may have significant potential for radiotherapy treatment optimisation [1] [2] [3] . Radiation induced non-targeted effects have been reported for a range of biological endpoints [4] [5] [6] [7] [8] [9] including the induction of the DNA damage marker γH2AX [10] [11] [12] [13] [14] [15] .
Most recently, ataxia-telangiectasia and Rad3-related (ATR) has been identified as a central player within the bystander signalling cascade that is responsible for H2AX phosphorylation. The ataxia-telangiectasia mutated (ATM) protein was found to be activated downstream of ATR [16] and ATR-mediated, S-phase dependent γH2AX and 53BP1 foci induction was observed [11] . These observations support the hypothesis of an accumulation of replication-associated DNA damage in bystander cells. DNA replication fork stalling can be caused by DNA damage through reactive oxygen or nitrogen species which are thought to play a central role in DNA damage induction in bystander cells. ATR is involved in the recognition of stalled replication forks, failure to stabilise them results in their collapse and ultimately in genetic instability (reviewed in [17] ). The report of S-phase specific DNA damage recognised through an ATR and H2AX dependent mechanism in bystander cells strongly suggests the subsequent activation of the Fanconi Anaemia (FA)/BRCA network which is a key pathway in the homologous recombination-dependent resolution of stalled replication and regulation of the intra-S-phase cell cycle checkpoint [18] [19] [20] . Phosphorylation of FANCD2 by either ATR or ATM is required for the induction of an intra-S-phase arrest. FA core proteins, ATR and RPA1 [21] are required for the ubiquitination of the FANCD2 protein in S-phase, a modification that is prerequisite for the accumulation at sites of DNA damage to form microscopically visible nuclear foci which associate with BRCA1, BRCA2 and RAD51. γH2AX in connection with BRCA1 recruits FANCD2 to chromatin at stalled replication forks [22] suggesting that H2AX is functionally linked to the FA/BRCA pathway to resolve stalled replication forks and prevent chromosome instability.
The cell cycle checkpoint kinase Chk1 is regulated by ATR and is involved in the activation of the FA/BRCA pathway through phosphorylation of FANCE [23] . The G(2)/M [24] and S-phase DNA damage checkpoints require Chk1 activation [25] .
The FA/BRCA DNA repair pathway is frequently affected in breast cancer where BRCA1 or BRCA2 mutations can be found in approximately 10% of cases.
Epigenetic silencing of BRCA1 occurs in 13% of breast cancers, 6% of cervical cancers and 4% of non-small-cell lung cancers. FANCF methylation is found in 30% of cervical cancer, 14% of squamous cell head and neck cancers, 6.7% of germ cell tumours of testis, and 15% of non-small-cell lung cancers [26] .
This study investigates the hypothesis of an activation of the FA/BRCA network in the radiation-induced bystander response at sites of stalled replication promoting both DNA repair by homologous recombination and intra-S-phase checkpoint activation in bystander cells which is supported by our previous report of an S-phase restricted, ATR dependent formation of γH2AX and 53BP1 foci in bystander cells [11, 16] . For medium transfer experiments cells were seeded on 22 x 22 mm 2 coverslips placed in 6-well tissue culture dishes and treated with filtered medium obtained from T98G cells, which had been irradiated with 2 Gy of X-rays (Pantak, X-ray set, 240KV) at 37C. Following 30 min incubation the medium was taken off and filtered using a 0.45 µm syringe filter. The recipient cells were incubated with the conditioned medium at 37C, 5 % CO 2 for 24 h followed by fixation and immunocytochemistry. Sham-treated cells were used as controls. For direct irradiations, cells were seeded on 22 x 22 mm 2 coverslips placed in 6-well tissue culture dishes and irradiated in cell culture medium at 37C with 1 and/or 5 Gy of X-rays (Pantak, X-ray set, 240KV) to induce similar BRCA1 and FANCD2 foci yields as those observed in bystander cells. Cells were incubated at 37C, 5 % CO 2 for 4 h after direct radiation before fixation and immunocytochemistry.Caffeine (Sigma, Poole, UK) was used at a concentration of 1 mM which has been demonstrated and is being widely used to inhibit ATR and ATM [27] [28] [29] . The specific ATM inhibitor (ATMi) Ku55933 was used at a concentration of 10 µM.
Materials and Methods

Cell Culture and irradiations
Bromodeoxyuridine labelling of DNA
In order to visualise stalled replication forks in bystander cells, sub-confluent T98G cells were labelled with bromodeoxyuridine (BrdU) for 21 h, treated with conditioned medium from irradiated cells for 3 h, then stained for BrdU nuclear foci (rat anti-BrdU, Cancer Research UK) applying a protocol without prior DNA denaturation [30] which relies on the recognition of single stranded, BrdUlabelled DNA at sites of replication fork stalling. For γH2AX co-localisation with BrdU foci, the BrdU staining protocol was combined with the γH2AX staining protocol described below.
A routine BrdU pulse labelling method was used to determine the fraction of 
Immunocytochemistry
Western Blot
Cells were lysed in buffer (1% Igepal, 0.1% SDS, 0.05% sodium deoxycholate, 1 protease inhibitor tablet and 1 PhosSTOP tablet (Roche, UK)) and protein concentration determined using the BCA assay (Pierce, UK) according to manufacturer"s instructions. Samples were then subject to SDS-PAGE electrophoresis using the XCell SureLock Mini-Cell system (Invitrogen, UK), transferred onto nitrocellulous membranes (Millipore, UK), blocked for 1h in 3% skim milk blocking solution and probed accordingly. Antibody binding was detected using Supersignal West Pico or Femto Chemiluminescent substrate (Pierce, UK) according to manufacturer"s instructions. Antibodies: antiphospho Chk1 S345 diluted 1:500 (Cell Signalling, UK), anti-BRCA1 diluted 1:500 (Santa Cruz) and anti-β Actin diluted 1:2500 (Sigma, UK).
Clonogenic Assay
500 cells were seeded in each T25 tissue culture flask containing filtered medium derived from irradiated (2 Gy, X-rays) or sham-irradiated cells, and incubated for 10 individual radiation doses were 0, 1, 2 and 5 Gy, with 500, 1000, 2000 and 5000 cells seeded per flask, respectively. Flasks were stained with crystal violet staining solution, and individual colonies were counted. Average surviving fractions and standard errors (SEM) of 2 -4 independent experiments performed in triplicates were calculated. The Chk1 inhibitor UCN-01 (7hydroxystauosporine) [31, 32] was added to the culture medium at a final concentration of 10 nM 15 min prior to direct irradiation, or was added into the conditioned medium prior to transfer to recipient cells for bystander experiments. Colocalisation analysis of BrdU and γH2AX foci was analysed with ImageJ software using Pearson correlation coefficients [33] and Costes" spatial statistics method [34] .
Data analysis
Results
1 Stalled replication forks in bystander cells
On the basis of published cell cycle distribution data of bystander cells and the Sphase specificity of bystander foci formation [11, 16] we postulated that γH2AX and 53BP1 foci form at sites of stalled replication forks during S phase in bystander cells. To test this hypothesis, T98G glioma cells were cultured in BrdUcontaining medium for 21 h resulting in overall labelling of DNA during one cycle of DNA replication followed by incubation with filtered conditioned medium Figure 1C shows that the percentage of BrdU-positive cells increases significantly in T98G (p=0.01) and 48BR hTERT bystander cells (p=0.05), compared to controls. In contrast, no significant increase was detected in ATR-deficient FO2/98 hTERT and ATM-deficient GM05849 human fibroblasts. Figure 1D shows the persistent increase of γH2AX foci in cultures of bystander T98G cells over a period of 24 h.
FANCD2 and BRCA1 foci induction in bystander cells
Immunostaining for BRCA1 and FANCD2 was performed to determine the involvement of the BRCA/FA network in bystander signalling.
Directly irradiated T98G cells received an X-ray dose of 5 Gy and were subsequently stained for BRCA1 nuclear foci after 4 h incubation time. For the detection of BRCA1 bystander foci, cells were treated for 24 h with filtered medium derived from T98G cells irradiated with 2 Gy of X-rays ( Figure 2A ; see Supplementary Figure S2 for additional representative immunofluorescence microscopy images). Bystander cells showed a significant induction of BRCA1 foci above background level (p=0.02, Figure 2C ) although the fraction of cells without any foci remained at control level ( Figure 2B ). This finding is consistent with the S-phase dependence of bystander foci formation, as cells without foci are known to be mostly in the G1 phase of the cell cycle [11, 16] . In contrast, high numbers of nuclear BRCA1 foci were induced in all directly irradiated cells, without any sign of a "resistent" subpopulation ( Figure 2B ). In this context it should be noted that the T98G control cultures analysed here contained 42±4 % S phase cells (BrdU-positive following pulse-labelling for 15 min), rising to 53±4 % in bystander cells, measured using flow cytometry (raw data not shown). addressed in greater detail [11, 16] , support the hypothesis of an S-phase dependent bystander DNA damage response involving γH2AX, BRCA1 and FANCD2.
BRCA1 and FANCD2 foci in ATR/ATM mutant cell lines, ATMinhibited and caffeine treated cells
The reduction in clonogenic survival of bystander cells depends on ATR function and subsequent ATM activation [16] whereas bystander γH2AX foci induction requires ATR but not ATM [11] . To determine whether ATR and/or ATM are involved in the activation of the BRCA/FA network in bystander cells, ATR mutant F02-98 hTERT cells, ATM deficient GM05849 cells and ATMi or caffeine treated T98G cells were treated with conditioned medium derived from irradiated T98G cells and analysed for the induction of BRCA1 and FANCD2 foci ( Figure 4A and 4B) in comparison to T98G cells.
FANCD2 bystander foci were detected in T98G (p<0.01), ATMi-treated and ATMdeficient GM05849 cells (p<0.01) but not in ATR mutated F02-98 hTERT cells and T98G cells treated with the ATR/ATM inhibitor caffeine. This indicates that ATR, but not ATM, is required for the recruitment of FANCD2 to sites of replication associated DNA damage in bystander cells.
BRCA1 bystander foci were induced in T98G cells (p=0.02) but not in ATR mutated F02-98 hTERT, ATM deficient GM05849 or ATMi or caffeine treated T98G cells. These results suggest an essential role for ATM in the formation of nuclear BRCA1 foci in bystander cells. As shown previously [16] , the activation of ATM in bystander cells depends on functional ATR. Therefore, the inactivation of either ATR or ATM prevents the formation of BRCA1 nuclear foci in bystander cells.
Phosphorylation of Chk1 in bystander cells and inhibition of a clonogenic bystander effect by the Chk1 inhibitor UCN-01
Chk1 is a main downstream target of ATR and is involved in the activation of the BRCA/FA pathway [23] . Therefore, we tested the hypothesis of bystander Chk1 activation which could provide a functional link between activation of ATR and BRCA/FA in bystander cells. Cells were treated for 24 h with filtered medium derived from 2 Gy X-irradiated T98G cells and immunostained for phospho-Chk1 (p348S). Significantly increased phospho-Chk-1 foci formation was observed in T98G bystander cells (p<0.01, Figure 5A In order to test the functional importance of Chk1 in bystander responses, T98G cells were treated with the Chk1 inhibitor UCN-01 one hour prior to radiation and during subsequent incubation for colony formation in a clonogenic assay. A concentration of 10 nM resulted in a moderate radiosensitisation of T98G cells (p<0.05, Figure 6A ). Bystander cells were treated with medium derived from T98G cells treated with 10 nM UCN-01 and irradiated with 2 Gy. Whereas shamtreated controls showed a significant reduction of the clonogenic survival of bystander cells (p<0.05), UCN-01-treated cultures were protected and showed only a minor non-significant bystander effect ( Figure 6B ). In T98G cells, higher doses of UCN-01 were toxic and could therefore not be tested for a further increase of the effect.
Discussion
This study aims to further clarify the DNA damage response network in bystander cells and to identify potential targets for novel molecular inhibitors. We have previously shown the S-phase restricted induction of γH2AX nuclear foci in an ATR dependent manner and the activation of ATM downstream of ATR in bystander cells [11, 16] . Over the past few years, a novel FA/BRCA DNA damage response pathway has been uncovered which is a key pathway in the resolution of stalled replication and regulation of the intra-S-phase cell cycle checkpoint [20] . Functional loss of members of this pathway is linked to genomic instability [35] . repair network that has been uncovered in recent years [18] [19] [20] [21] [22] [23] 56] . Future studies are required as this is beyond the scope of this current study.
While this study does not directly demonstrate that FANCD2 bystander foci form in S-phase cells, there is a strong line of argumentation from our previously published bystander studies and this current study to support this interpretation:
(i) It has been thoroughly demonstrated that γH2AX foci are formed in S-phase cells via co-staining with CENP-F [11] ; (ii) γH2AX foci co-localise with BrdU foci, highlighting replication fork stalling; (iii) γH2AX foci co-localise with BRCA1, ATR and ATM foci in bystander cells [16] ; (iv) FANCD2 and γH2AX foci co-localise in bystander cells (Supplementary Figure 5) .
Interestingly, a recent study by Redon et al. suggests that malignant tumours
induce a DNA damage response in proliferating distant tissue similar to the DNA damage response in the proposed bystander model [36, 37] .
A previous study has demonstrated that the bystander effect observed in a coculture of targeted and non-targeted cells persists for at least 24 h following irradiation, using γH2AX foci induction in T98G cells as experimental system ( Figure 3 in [11] ). In this study, a persistent increase of γH2AX bystander foci for at least 24 h has also been confirmed for medium transfer experiments. This observation is supported by two independent reports by Facoetti et al. [38] and Zhang et al. [39] who also report a persistent bystander response in medium transfer experiments involving different endpoints than gamma-H2AX foci formation. However, no data have been obtained yet on the dose dependence of bystander foci induction. Yet, based on the general observation of doseindependent bystander effects (e.g. Figure 4 from [4] ) one would not expect to see a difference for conditioned medium obtained from cells exposed to different doses.
The nature of the signal triggering a DNA damage response in non-targeted cells is still not entirely clear. Subnuclear foci of γH2AX and 53BP1 are well known to be associated with DNA double-strand breaks but their formation in bystander cells likely reflects only a secondary event triggered by stalled replication forks rather than prompt "two-ended" DSBs. These stalled replication forks have been postulated to be a consequence of an accumulation of ROS leading to DNA damage, including base damage which accumulates in S-phase leading to replication fork stalling and secondary production of DSBs and chromosomal aberrations [40] . Increasing ROS levels following treatment with conditioned medium from irradiated cells have previously been reported [41] . The results presented suggest that bystander signals act in a similar manner as inter-strand crosslinks [42] , ultraviolet light-induced damage [43] , and human papillomavirus type 16 E7 oncoprotein-mediated replication stress [44] . All these factors activate the FA/BRCA pathway and may not directly induce DSBs but rather lead to secondary DNA breaks that form during replication, for example when the replication fork encounters an unrepaired single-strand break. Such "one-ended" breaks are normally repaired via homologous recombination-dependent processes. The previous observation that sister chromatid exchanges are induced in bystander cells [45] in a homologous recombination-dependent manner [46] is consistent with this concept.
A central role for Chk1 in the activation of the BRCA/FA network has been reported previously [23] . Our results show an activation of Chk1 in the radiationinduced bystander DNA damage response and suggest the suitability of Chk1 as a further potential target to differentially modulate radiation effects on directly irradiated and non-targeted bystander cells. In a similar manner to the Chk1 response reported here, where the Chk1 inhibitor UCN-1 acted as a radiosensitizer in directly radiated cells but increased survival in bystander cells ( Figure 6 ), ATR and ATM inhibitors have previously been demonstrated to differentially modulate targeted and bystander responses for the endpoint of clonogenic cell survival [16] . It is thought that inhibition of the repair proteins involved in the bystander response may increase the survival of damaged cells which may otherwise have undergone cell cycle arrest or apoptosis. However, this hypothesis has not been tested yet and will be the subject of future studies.
The FA/BRCA pathway is affected in many human tumours including bladder [47] , breast [48] and cervical [49] cancer either through gene mutations or epigenetic changes, and inherited mutation in either BRCA1 or BRCA2 causes a hereditary breast and ovarian cancer syndrome. Many of these cancers are treated with radiotherapy. Investigating the role of this pathway in the response to radiation-induced DNA damage is therefore important for treatment optimisation.
Especially pathways targeted by novel molecular inhibitors (e.g. PARP inhibitors in BRCA mutated tumours [50] , ATM inhibitors or Chk1 inhibitors) with the potential for combined radiotherapy [51] need to be investigated regarding their effects on directly irradiated and bystander cells. Furthermore, increased clinical as well as cellular radiosensitivity has been reported for some but not all patients with inherited defects in the FA/BRCA pathway [52] [53] [54] [55] [56] [57] [58] [59] , adding to the complexity of radiotherapy treatment optimisation.
Limiting the radiation induced genomic damage of normal cells, which may further lead to cancer formation is key in the field of radiation protection. Furthermore, radiation induced bystander cells are at risk for late genomic instability, which is associated with many cancers. Further studies on genomic instability in bystander cells will be needed to understand the possible mechanisms of secondary cancers after radiation exposure. Bystander cells
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